Exforge

Exforge&reg; is the brand name of an oral antihypertensive medication which combines two antihypertensive agents in a film-coated tablet. It contains amlodipine, a calcium channel blocker, and valsartan, an angiotensin-2 receptor antagonist (ARB or A2A). The patent is held by Novartis Pharmaceuticals.

Exforge is available in different dose preparations: 5mg/160mg, 10mg/160mg,5mg/320mg and 10/3200mg's of amlodipine and valsartan respectively.